Effectiveness, safety and cost analysis of add-on pidotimod in maintenance therapy for exacerbation of chronic obstructive pulmonary disease in adults

Journal Title: IP Indian Journal of Immunology and Respiratory Medicine - Year 2018, Vol 3, Issue 4

Abstract

Acute exacerbation of chronic obstructive pulmonary disease AECOPD is the sudden worsening in airway function and respiratory symptoms in patients with COPD which range from selflimited diseases to episodes of florid respiratory failure requiring mechanical ventilation An average patient with COPD might experience 2 episodes of AECOPD per year and 10 of these episodes require hospitalization Pidotimod an immunostimulant has shown promising results in conditions with underlying cause of suppressed cellmediated immunity like chronic bronchitis and recurrent respiratory tract infection RRTI The current study evaluated the safety efficacy and cost effectiveness of Pidotimod in adult Indian patients with COPD as an addon drug in maintenance therapy of acute exacerbations In this prospective open label single arm single centre study Pidotimod was administered as an addon therapy for 2 months in 114 patients 18 years and 55years mean age 5951 866 years with COPD having experienced two or more exacerbation that required antibiotics The study comprised of screening visit enrolment and 3 followup visits at the end of 2 6 and 12 months Of the 111 patients at baseline only one patient had an AECB episode at 2 and 6 months At the end of 12 months none of the patient had an AECB Only one subject was prescribed with antibiotic treatment at the end of 2 and 6 months No episodes of either exacerbations or antibiotic prescription at the end of 12 months were reported A significant reduction pKeywords Immunostimulant Pidotimod Acute exacerbations of chronic bronchitis AECB Costanalysis Respiratory infections

Authors and Affiliations

Ashish Goyal

Keywords

Related Articles

In vitro analysis of allergens among patients with Asthma - A clinical study

Background Allergy is one of most basic immunological response which happens after exposure to substances which are safe to dominant part of individuals On the planet 2030 of the tenants are known to experience the ill e...

Management of cold Abscess: A novel approach

Percutaneous abscess drainage is a widely accepted method of treatment of an accessible abscess Consistently poor results have been reported by various authors due to presence of infected hematomas or presence of thick v...

Changing trends in aetiology and antibiotic resistance of symptomatic community acquired bacterial pneumonia in hospitalised adult patients -A South Indian study

Background Community Acquired Pneumonia CAP of bacterial origin in adults is a leading cause of mortality and morbidity in developing countries Etiological diagnosis plays a significant role in hospitalised patients for...

A rare association of Kartagener's syndrome with mixed connective tissue disorder

We hereby, present a female with Kartagener’s syndrome associated with mixed connective tissue disorder. Kartagener’s syndrome is a rare congenital malformation comprising triad of sinusitis, situs inversus and bronchiec...

Bacteriological profile of acute exacerbations of chronic obstructive pulmonary disease

Introduction Acute exacerbations of chronic obstructive pulmonary disease COPD influence the quality of life and account for considerable morbidity and mortality Several factors contribute to the etiology of COPD exacerb...

Download PDF file
  • EP ID EP490623
  • DOI 10.18231/2581-4222.2018.0049
  • Views 61
  • Downloads 0

How To Cite

Ashish Goyal (2018). Effectiveness, safety and cost analysis of add-on pidotimod in maintenance therapy for exacerbation of chronic obstructive pulmonary disease in adults. IP Indian Journal of Immunology and Respiratory Medicine, 3(4), 203-209. https://europub.co.uk/articles/-A-490623